Compare ImmunityBio Inc. Common Stock (IBRX) vs MaxLinear Inc. Common Stock (MXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs MaxLinear Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B), while MaxLinear Inc. Common Stock trades at $96.16 (market cap $8.50B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, MaxLinear Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and MaxLinear Inc. Common Stock for 1 Days on average.
| IBRX | MXL | |
|---|---|---|
Market Cap | $10.51B | $8.50B |
Volume | 10,445,785 | 4,008,439 |
Sector | Health | Technology |
52-Week High | $11.55 | $128.03 |
52-Week Low | $1.98 | $13.05 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $8.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About MaxLinear Inc. Common Stock
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →
